Wednesday 20 September, 2017

Cow immune system inspires new therapies for humans


Scientists have developed a potential new therapy based on immune molecules from cows to help people with hormone deficiencies.  More...

by BioNews | Published 3 years ago
Smartphone dongles performed a point-of-care HIV and syphilis test in Rwanda from finger prick whole blood in 15 minutes, operated by health care workers trained on a software app.
—Image courtesy of Samiksha Nayak for Columbia Engineering
By BioNews On Thursday, February 5th, 2015

Smartphone device can diagnose HIV in 15 minutes

A team of researchers from Columbia University has developed a low-cost smartphone accessory or dongle that can perform a test that simultaneously detects three infectious disease markers from a finger prick of More...

syk signaling B Cells
By BioNews On Friday, January 30th, 2015

Scientists show mature B cells can survive without the tyrosine kinase Syk.

B lymphocytes are an integral part of our adaptive immune system and their development and function is tightly regulated by several signaling pathways.  More...

cell immunity environment
By BioNews On Monday, January 19th, 2015

Environment not genes decides immunity as we age

After studying twins, researchers from Stanford University show that our environment, more than our heredity  More...

HIV failure
By BioNews On Saturday, January 3rd, 2015

What makes HIV vaccines backfire?

The very immune cells that HIV vaccines aim to increase may already have been affected by the virus, a reason why AIDS  More...

By BioNews On Tuesday, December 23rd, 2014

Two Ebola vaccines safe, confirms trial

A trial of two experimental DNA vaccines to prevent Ebola virus has confirmed  More...

By BioNews On Saturday, December 20th, 2014

Cells that facilitate tumour growth identified

A recent study has identified the population of white blood cells that tumours use to enhance growth and suppress the disease-fighting immune system. The results mark a turning point in cancer immunology and provide More...

A 39-year-old woman, the first participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Maryland. on Sept. 2, 2014.  (Image Credit: NIH/NIAID)
By BioNews On Monday, December 1st, 2014

New Ebola Vaccine developed by NIH/GSK appears safe and effective in Phase 1 Clinical Trials

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20  More...

ebola virus
By BioNews On Monday, December 1st, 2014

Ebola vaccine showing promising results

Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West  More...

Localization of the stabilizing disulfide bonds and schematic representation of the heterodimers. (Image Credit: PLOS One)
By BioNews On Sunday, November 30th, 2014

Researchers developed a new vaccine to prevent Lyme Disease

European biotechnology company Valneva SE (Valneva) announced today that an article, presenting for the first time the pre-clinical  More...